Chaoqun Mei

Machine Learning Algorithm Predicts Cardiac Resynchronization Therapy Outcomes

Matthew M. Kalscheur, Ryan Kipp, Matthew C. Tattersall et al. · Circulation Arrhythmia and Electrophysiology · 2018 · 110 citations · Full text

Medicine, Biostatistics, Cardiology +17

Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial

Matthew M. Kalscheur, Leslie A. Saxon, Byron K. Lee et al. · Heart Rhythm · 2017 · 34 citations

Medicine, Cardiology, Clinical Cardiology +7

Efficacy and Safety with Extended Follow-up in a Phase 1 Study of BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patients (pts) with Heavily Pretreated Relapsed/Refractory (RR) Multiple Myeloma (MM)

Susan Bal, Larry D. Anderson, Omar Nadeem et al. · Blood · 2024 · 22 citations

Medicine, Immunology, Oncology +17

The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy

Bethany Doran, Chaoqun Mei, Paul D. Varosy et al. · JACC Heart Failure · 2021 · 20 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Efficacy and Safety of Golcadomide, a Novel Cereblon E3 Ligase Modulator (CELMoD) Agent, Combined with Rituximab in a Phase 1/2 Open-Label Study of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Julio C. Chávez, Loretta J. Nastoupil, Franck Morschhauser et al. · Blood · 2023 · 14 citations

Medicine, Pharmacology, Pharmacotherapy +15